Literature DB >> 18028977

Recruitment of Alix/AIP1 to the plasma membrane by Sendai virus C protein facilitates budding of virus-like particles.

Takashi Irie1, Natsuko Nagata, Tetsuya Yoshida, Takemasa Sakaguchi.   

Abstract

Sendai virus (SeV) is unique in that one of the viral accessory proteins, C, enhances budding of virus-like particles (VLPs) formed by SeV matrix protein M by physically interacting with Alix/AIP1. C protein itself does not have the ability to form VLPs, while M protein provides viral budding force, like other enveloped viruses. Here we show that SeV C protein recruits Alix/AIP1 to the plasma membrane (PM) to facilitate VLP budding. SeV M-VLP budding is sensitive to overexpression of a dominant-negative (DN) form of VPS4A only in the presence of the C proteins, which is able to recruit Alix/AIP1 to the PM. Our results indicate that SeV M and C proteins play separate roles in the budding process: M protein drives budding and C protein enhances the efficiency of the utilization of cellular MVB sorting machinery for efficient VLP budding.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18028977     DOI: 10.1016/j.virol.2007.09.020

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  30 in total

1.  Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA.

Authors:  Maria Teresa Sánchez-Aparicio; Dominique Garcin; Charles M Rice; Daniel Kolakofsky; Adolfo García-Sastre; Alina Baum
Journal:  J Gen Virol       Date:  2017-06-20       Impact factor: 3.891

2.  Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein.

Authors:  Takashi Irie; Katsuhiro Kiyotani; Tomoki Igarashi; Asuka Yoshida; Takemasa Sakaguchi
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

Review 3.  Nipah virus matrix protein: expert hacker of cellular machines.

Authors:  Ruth E Watkinson; Benhur Lee
Journal:  FEBS Lett       Date:  2016-07-12       Impact factor: 4.124

4.  Sendai virus C proteins regulate viral genome and antigenome synthesis to dictate the negative genome polarity.

Authors:  Takashi Irie; Isao Okamoto; Asuka Yoshida; Yoshiyuki Nagai; Takemasa Sakaguchi
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

5.  EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells.

Authors:  Jin Qiu; David A Thorley-Lawson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-10       Impact factor: 11.205

6.  An integrated protein localization and interaction map for Potato yellow dwarf virus, type species of the genus Nucleorhabdovirus.

Authors:  Anindya Bandyopadhyay; Kristin Kopperud; Gavin Anderson; Kathleen Martin; Michael Goodin
Journal:  Virology       Date:  2010-04-01       Impact factor: 3.616

Review 7.  Paramyxovirus assembly and budding: building particles that transmit infections.

Authors:  Megan S Harrison; Takemasa Sakaguchi; Anthony P Schmitt
Journal:  Int J Biochem Cell Biol       Date:  2010-04-14       Impact factor: 5.085

8.  Detection of the Endosomal Sorting Complex Required for Transport in Entamoeba histolytica and Characterization of the EhVps4 Protein.

Authors:  Israel López-Reyes; Guillermina García-Rivera; Cecilia Bañuelos; Silvia Herranz; Olivier Vincent; César López-Camarillo; Laurence A Marchat; Esther Orozco
Journal:  J Biomed Biotechnol       Date:  2010-05-17

9.  Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses.

Authors:  Takashi Irie; Natsuko Nagata; Tomoki Igarashi; Isao Okamoto; Takemasa Sakaguchi
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

10.  Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor.

Authors:  Grégory Caignard; Anastassia V Komarova; Mehdi Bouraï; Thomas Mourez; Yves Jacob; Louis M Jones; Flore Rozenberg; Astrid Vabret; François Freymuth; Frédéric Tangy; Pierre-Olivier Vidalain
Journal:  PLoS Pathog       Date:  2009-09-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.